, a Susceptibility Gene for Type 1 and Type 2 Diabetes, Modulates Pancreatic Beta Cell Apoptosis via Regulation of a Splice Variant of the BH3-Only Protein

English version České info

Mutations in human Gli-similar (GLIS) 3 protein cause neonatal diabetes. The GLIS3 gene region has also been identified as a susceptibility risk locus for both type 1 and type 2 diabetes. GLIS3 plays a role in the generation of pancreatic beta cells and in insulin gene expression, but there is no information on the role of this gene on beta cell viability and/or susceptibility to immune- and metabolic-induced stress. GLIS3 knockdown (KD) in INS-1E cells, primary FACS-purified rat beta cells, and human islet cells decreased expression of MafA, Ins2, and Glut2 and inhibited glucose oxidation and insulin secretion, confirming the role of this transcription factor for the beta cell differentiated phenotype. GLIS3 KD increased beta cell apoptosis basally and sensitized the cells to death induced by pro-inflammatory cytokines (interleukin 1β + interferon-γ) or palmitate, agents that may contribute to beta cell loss in respectively type 1 and 2 diabetes. The increased cell death was due to activation of the intrinsic (mitochondrial) pathway of apoptosis, as indicated by cytochrome c release to the cytosol, Bax translocation to the mitochondria and activation of caspases 9 and 3. Analysis of the pathways implicated in beta cell apoptosis following GLIS3 KD indicated modulation of alternative splicing of the pro-apoptotic BH3-only protein Bim, favouring expression of the pro-death variant Bim_S via inhibition of the splicing factor SRp55. KD of Bim abrogated the pro-apoptotic effect of GLIS3 loss of function alone or in combination with cytokines or palmitate. The present data suggest that altered expression of the candidate gene GLIS3 may contribute to both type 1 and 2 type diabetes by favouring beta cell apoptosis. This is mediated by alternative splicing of the pro-apoptotic protein Bim and exacerbated formation of the most pro-apoptotic variant Bim_S.

Vyšlo v časopise: , a Susceptibility Gene for Type 1 and Type 2 Diabetes, Modulates Pancreatic Beta Cell Apoptosis via Regulation of a Splice Variant of the BH3-Only Protein. PLoS Genet 9(5): e32767. doi:10.1371/journal.pgen.1003532
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1003532

Souhrn

Zdroje

1. SeneeV, ChelalaC, DuchateletS, FengD, BlancH, et al. (2006) Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism. Nat Genet 38: 682–687.

2. DimitriP, WarnerJT, MintonJA, PatchAM, EllardS, et al. (2011) Novel GLIS3 mutations demonstrate an extended multisystem phenotype. Eur J Endocrinol 164: 437–443.

3. BarrettJC, ConcannonP, AkolkarB, CooperJD, ErlichHA, et al. (2009) Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 41: 703–707.

4. DupuisJ, ProkopenkoI, SaxenaR, SoranzoN, JacksonAU, et al. (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42: 105–116.

5. BoesgaardTW, GrarupN, JorgensenT, Borch-JohnsenK, HansenT, et al. (2010) Variants at DGKB/TMEM195, ADRA2A, GLIS3 and C2CD4B loci are associated with reduced glucose-stimulated β-cell function in middle-aged Danish people. Diabetologia 53: 1647–1655.

6. LiH, GanW, LuL, DongX, HanX, et al. (2012) A Genome-Wide Association Study Identifies GRK5 and RASGRP1 as Type 2 Diabetes Loci in Chinese Hans. Diabetes 62: 291–298.

7. ChoYS, HuC, LongJ, OngRT, SimX, et al. (2011) Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians. Nat Genet 44: 67–72.

8. BarkerA, SharpSJ, TimpsonNJ, Bouatia-NajiN, WarringtonNM, et al. (2011) Association of genetic Loci with glucose levels in childhood and adolescence: a meta-analysis of over 6,000 children. Diabetes 60: 1805–1812.

9. Kang HSKY, ZeRuthG, BeakJY, GerrishK, KilicG, et al. (2009) Transcription factor Glis3, a novel critical player in the regulation of pancreatic β-cell development and insulin gene expression. Mol Cell Biol 29: 6366–6379.

10. WatanabeNHK, MiyamotoR, YasudaK, SuzukiN, OshimaN, et al. (2009) A murine model of neonatal diabetes mellitus in Glis3-deficient mice. FEBS Lett 583: 2108–2113.

11. YangY, ChangBH, ChanL (2012) Sustained expression of the transcription factor GLIS3 is required for normal beta cell function in adults. EMBO Mol Med 5: 92–104.

12. YangY, ChangBH, SamsonSL, LiMV, ChanL (2009) The Kruppel-like zinc finger protein Glis3 directly and indirectly activates insulin gene transcription. Nucleic Acids Res 37: 2529–2538.

13. CnopM, WelshN, JonasJC, JornsA, LenzenS, et al. (2005) Mechanisms of pancreatic β-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54(Suppl 2): S97–107.

14. EizirikDL, ColliML, OrtisF (2009) The role of inflammation in insulitis and β-cell loss in type 1 diabetes. Nat Rev Endocrinol 5: 219–226.

15. AhlqvistE, AhluwaliaTS, GroopL (2011) Genetics of type 2 diabetes. Clin Chem 57: 241–254.

16. McCarthyMI (2010) Genomics, type 2 diabetes, and obesity. N Engl J Med 363: 2339–2350.

17. VoightBF, ScottLJ, SteinthorsdottirV, MorrisAP, DinaC, et al. (2012) Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 42: 579–589.

18. MooreF, ColliML, CnopM, EsteveMI, CardozoAK, et al. (2009) PTPN2, a candidate gene for type 1 diabetes, modulates interferon-γ-induced pancreatic β-cell apoptosis. Diabetes 58: 1283–1291.

19. ColliML, MooreF, GurzovEN, OrtisF, EizirikDL (2010) MDA5 and PTPN2, two candidate genes for type 1 diabetes, modify pancreatic β-cell responses to the viral by-product double-stranded RNA. Hum Mol Genet 19: 135–146.

20. SantinI, MooreF, ColliML, GurzovEN, MarselliL, et al. (2011) PTPN2, a candidate gene for type 1 diabetes, modulates pancreatic β-cell apoptosis via regulation of the BH3-only protein Bim. Diabetes 60: 3279–3288.

21. EizirikDL, SammethM, BouckenoogheT, BottuG, SisinoG, et al. (2012) The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines. PLoS Genet 8: e1002552 doi:10.1371/journal.pgen.1002552.

22. BergholdtR, BrorssonC, PallejaA, BerchtoldLA, FloyelT, et al. (2012) Identification of novel type 1 diabetes candidate genes by integrating genome-wide association data, protein-protein interactions, and human pancreatic islet gene expression. Diabetes 61: 954–962.

23. ColliML, NogueiraTC, AllagnatF, CunhaDA, GurzovEN, et al. (2011) Exposure to the viral by-product dsRNA or Coxsackievirus B5 triggers pancreatic β-cell apoptosis via a Bim/Mcl-1 imbalance. PLoS Pathog 7: e1002267 doi:10.1371/journal.ppat.1002267.

24. CardozoAK, OrtisF, StorlingJ, FengYM, RasschaertJ, et al. (2005) Cytokines downregulate the sarcoendoplasmic reticulum pump Ca2+ ATPase 2b and deplete endoplasmic reticulum Ca2+, leading to induction of endoplasmic reticulum stress in pancreatic β-cells. Diabetes 54: 452–461.

25. AllagnatF, FukayaM, NogueiraTC, DelarocheD, WelshN, et al. (2012) C/EBP homologous protein contributes to cytokine-induced pro-inflammatory responses and apoptosis in β-cells. Cell Death Differ 19: 1836–1846.

26. EizirikDL, CnopM (2010) ER stress in pancreatic β-cells: the thin red line between adaptation and failure. Sci Signal 3: pe7.

27. GurzovEN, EizirikDL (2011) Bcl-2 proteins in diabetes: mitochondrial pathways of β-cell death and dysfunction. Trends Cell Biol 21: 424–431.

28. GurzovEN, OrtisF, CunhaDA, GossetG, LiM, et al. (2009) Signaling by IL-1β+IFN-γ and ER stress converge on DP5/Hrk activation: a novel mechanism for pancreatic β-cell apoptosis. Cell Death Differ 16: 1539–1550.

29. GurzovEN, GermanoCM, CunhaDA, OrtisF, VanderwindenJM, et al. (2010) p53 up-regulated modulator of apoptosis (PUMA) activation contributes to pancreatic β-cell apoptosis induced by proinflammatory cytokines and endoplasmic reticulum stress. J Biol Chem 285: 19910–19920.

30. BarthsonJ, GermanoCM, MooreF, MaidaA, DruckerDJ, et al. (2011) Cytokines tumor necrosis factor-α and interferon-γ induce pancreatic β-cell apoptosis through STAT1-mediated Bim protein activation. J Biol Chem 286: 39632–39643.

31. MooreF, SantinI, NogueiraTC, GurzovEN, MarselliL, et al. (2012) The transcription factor C/EBPδ has anti-apoptotic and anti-inflammatory roles in pancreatic β-cells. PLoS ONE 7: e31062 doi:10.1371/journal.pone.0031062.

32. O'ConnorL, StrasserA, O'ReillyLA, HausmannG, AdamsJM, et al. (1998) Bim: a novel member of the Bcl-2 family that promotes apoptosis. Embo J 17: 384–395.

33. CunhaDA, GurzovEN, GermanoCM, NaamaneN, MarhfourI, et al. (2012) DP5 and PUMA mediate the ER stress-mitochondrial dialog triggering lipotoxic β-cell apoptosis. Diabetes 61: 2763–2775.

34. LeuS, LinYM, WuCH, OuyangP (2012) Loss of Pnn expression results in mouse early embryonic lethality and cellular apoptosis through SRSF1-mediated alternative expression of Bcl-xS and ICAD. J Cell Sci 125: 3164–3172.

35. JiangCC, LaiF, TayKH, CroftA, RizosH, et al. (2010) Apoptosis of human melanoma cells induced by inhibition of B-RAFV600E involves preferential splicing of bimS. Cell Death Dis 1: e69.

36. FerdaoussiM, AbdelliS, YangJY, CornuM, NiederhauserG, et al. (2008) Exendin-4 protects β -cells from interleukin-1 β-induced apoptosis by interfering with the c-Jun NH2-terminal kinase pathway. Diabetes 57: 1205–1215.

37. CunhaDA, LadriereL, OrtisF, Igoillo-EsteveM, GurzovEN, et al. (2009) Glucagon-like peptide-1 agonists protect pancreatic β-cells from lipotoxic endoplasmic reticulum stress through upregulation of BiP and JunB. Diabetes 58: 2851–2862.

38. ButeauJ, El-AssaadW, RhodesCJ, RosenbergL, JolyE, et al. (2004) Glucagon-like peptide-1 prevents β-cell glucolipotoxicity. Diabetologia 47: 806–815.

39. KwonG, PappanKL, MarshallCA, SchafferJE, McDanielML (2004) cAMP Dose-dependently prevents palmitate-induced apoptosis by both protein kinase A- and cAMP-guanine nucleotide exchange factor-dependent pathways in β-cells. J Biol Chem 279: 8938–8945.

40. RajSM, HowsonJM, WalkerNM, CooperJD, SmythDJ, et al. (2009) No association of multiple type 2 diabetes loci with type 1 diabetes. Diabetologia 52: 2109–2116.

41. OwenKR, McCarthyMI (2009) Type 1 and type 2 diabetes-chalk and cheese? Diabetologia 52: 1983–1986.

42. WinklerC, RaabJ, GrallertH, ZieglerAG (2012) Lack of association of type 2 diabetes susceptibility genotypes and body weight on the development of islet autoimmunity and type 1 diabetes. PLoS ONE 7: e35410 doi:10.1371/journal.pone.0035410.

43. CervinC, LyssenkoV, BakhtadzeE, LindholmE, NilssonP, et al. (2008) Genetic similarities between latent autoimmune diabetes in adults, type 1 diabetes, and type 2 diabetes. Diabetes 57: 1433–1437.

44. MorrisAP, VoightBF, TeslovichTM, FerreiraT, SegrèAV, et al. (2012) Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet 44: 981–990.

45. MarselliL, ThorneJ, DahiyaS, SgroiDC, SharmaA, et al. (2010) Gene expression profiles of β-cell enriched tissue obtained by laser capture microdissection from subjects with type 2 diabetes. PLoS ONE 5: e11499 doi:10.1371/journal.pone.0011499.

46. TaneeraJ, LangS, SharmaA, FadistaJ, ZhouY, et al. (2012) A systems genetics approach identifies genes and pathways for type 2 diabetes in human islets. . Cell Metab 16: 122–134.

47. FujimotoK, ChenY, PolonskyKS, DornGW2nd (2010) Targeting cyclophilin D and the mitochondrial permeability transition enhances β-cell survival and prevents diabetes in Pdx1 deficiency. Proc Natl Acad Sci U S A 107: 10214–10219.

48. SachdevaMM, ClaibornKC, KhooC, YangJ, GroffDN, et al. (2009) Pdx1 (MODY4) regulates pancreatic β-cell susceptibility to ER stress. Proc Natl Acad Sci U S A 106: 19090–19095.

49. LeyR, EwingsKE, HadfieldK, CookSJ (2005) Regulatory phosphorylation of Bim: sorting out the ERK from the JNK. Cell Death Differ 12: 1008–1014.

50. WeberA, PaschenSA, HegerK, WilflingF, FrankenbergT, et al. (2007) BimS-induced apoptosis requires mitochondrial localization but not interaction with anti-apoptotic Bcl-2 proteins. J Cell Biol 177: 625–636.

51. ChenL, WillisSN, WeiA, SmithBJ, FletcherJI, et al. (2005) Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 17: 393–403.

52. McKenzieMD, JamiesonE, JansenES, ScottCL, HuangDC, et al. (2010) Glucose induces pancreatic islet cell apoptosis that requires the BH3-only proteins Bim and Puma and multi-BH domain protein Bax. Diabetes 59: 644–652.

53. MooreF, NaamaneN, ColliML, BouckenoogheT, OrtisF, et al. (2011) STAT1 is a master regulator of pancreatic β-cell apoptosis and islet inflammation. J Biol Chem 286: 929–941.

54. PuthalakathH, HuangDC, O'ReillyLA, KingSM, StrasserA (1999) The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol Cell 3: 287–296.

55. PanQ, ShaiO, LeeLJ, FreyBJ, BlencoweBJ (2008) Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet 40: 1413–1415.

56. EvsyukovaI, SomarelliJA, GregorySG, Garcia-BlancoMA (2010) Alternative splicing in multiple sclerosis and other autoimmune diseases. RNA Biol 7: 462–473.

57. OrtisF, NaamaneN, FlamezD, LadriereL, MooreF, et al. (2010) Cytokines interleukin-1β and tumor necrosis factor-α regulate different transcriptional and alternative splicing networks in primary β-cells. Diabetes 59: 358–374.

58. PipeleersDG, in't VeldPA, Van de WinkelM, MaesE, SchuitFC, et al. (1985) A new in vitro model for the study of pancreatic α and β cells. Endocrinology 117: 806–816.

59. RasschaertJ, LadriereL, UrbainM, DogusanZ, KatabuaB, et al. (2005) Toll-like receptor 3 and STAT-1 contribute to double-stranded RNA+ interferon-γ-induced apoptosis in primary pancreatic β-cells. J Biol Chem 280: 33984–33991.

60. LupiR, DottaF, MarselliL, Del GuerraS, MasiniM, et al. (2002) Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that β-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. Diabetes 51: 1437–1442.

61. MooreF, CunhaDA, MulderH, EizirikDL (2012) Use of RNA interference to investigate cytokine signal transduction in pancreatic β-cells. Methods Mol Biol 820: 179–194.

62. AllagnatF, CunhaD, MooreF, VanderwindenJM, EizirikDL, et al. (2011) Mcl-1 downregulation by pro-inflammatory cytokines and palmitate is an early event contributing to β-cell apoptosis. Cell Death Differ 18: 328–337.

63. HeimbergH, HeremansY, JobinC, LeemansR, CardozoAK, et al. (2001) Inhibition of cytokine-induced NF-κB activation by adenovirus-mediated expression of a NF-κB super-repressor prevents beta-cell apoptosis. Diabetes 50: 2219–2224.

64. EizirikDL, Mandrup-PoulsenT (2001) A choice of death–the signal-transduction of immune-mediated β-cell apoptosis. Diabetologia 44: 2115–2133.

65. EizirikDL, KutluB, RasschaertJ, DarvilleM, CardozoAK (2003) Use of microarray analysis to unveil transcription factor and gene networks contributing to β-cell dysfunction and apoptosis. Ann N Y Acad Sci 1005: 55–74.

66. CunhaDA, HekermanP, LadriereL, Bazarra-CastroA, OrtisF, et al. (2008) Initiation and execution of lipotoxic ER stress in pancreatic β-cells. J Cell Sci 121: 2308–2318.

67. CnopM, HannaertJC, HoorensA, EizirikDL, PipeleersDG (2001) Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation. Diabetes 50: 1771–1777.

68. ChenMC, ProostP, GysemansC, MathieuC, EizirikDL (2001) Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1β-exposed human and rat islet cells. Diabetologia 44: 325–332.

69. OverberghL, ValckxD, WaerM, MathieuC (1999) Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine 11: 305–312.

70. CardozoAK, KruhofferM, LeemanR, OrntoftT, EizirikDL (2001) Identification of novel cytokine-induced genes in pancreatic β-cells by high-density oligonucleotide arrays. Diabetes 50: 909–920.

71. PirotP, NaamaneN, LibertF, MagnussonNE, OrntoftTF, et al. (2007) Global profiling of genes modified by endoplasmic reticulum stress in pancreatic β-cells reveals the early degradation of insulin mRNAs. Diabetologia 50: 1006–1014.

72. EizirikDL, SandlerS, SenerA, MalaisseWJ (1988) Defective catabolism of D-glucose and L-glutamine in mouse pancreatic islets maintained in culture after streptozotocin exposure. Endocrinology 123: 1001–1007.

73. KutluB, CardozoAK, DarvilleMI, KruhofferM, MagnussonN, et al. (2003) Discovery of gene networks regulating cytokine-induced dysfunction and apoptosis in insulin-producing INS-1 cells. Diabetes 52: 2701–2719.

74. HoorensA, Van de CasteeleM, KloppelG, PipeleersD (1996) Glucose promotes survival of rat pancreatic β-cells by activating synthesis of proteins which suppress a constitutive apoptotic program. J Clin Invest 98: 1568–1574.